Efficacy and Safety of an Extravascular, substernally implanted Cardioverter–Defibrillator
28 August 2022
| The extravascular implantable cardioverter–defibrillator (ICD) has a single lead implanted substernally to enable pause-prevention pacing, antitachycardia pacing, and defibrillation energy similar to that of transvenous ICDs. The safety and efficacy of extravascular ICDs are not yet known. | |
| In this prospective global study, we found that extravascular ICDs were implanted safely and were able to detect and terminate induced ventricular arrhythmias at the time of implantation. | |
| Author(s) | Source |
| Friedman P Murgatroyd F, Boersma LVA et al. | The New England Journal of Medicine, August 28, 2022 DOI: 10.1056/NEJMoa2206485 |
| This is a post of a scientific or business information. The information given here is checked thoroughly by “Implant-Register”. However we can´t be responsible for the content. The content usually is shortened to make it understandable for many. Read the linked original text if you are interested. Contact the publisher, if you have questions. You may inform us about changes of the information to improve the Register. | |
| Comments: n/a let us know |
|
Find NEWS and PUBLICATIONS here according to your interests or use the search box.
